167298-40-0 Usage
Uses
Used in Pharmaceutical Industry:
Carbamic acid, [(1S)-3-oxocyclopentyl]-, 1,1-dimethylethyl ester (9CI) is used as a pharmaceutical intermediate for the synthesis of various medications. Its unique structure and properties make it a valuable component in the development of new drugs.
Used in Organic and Medicinal Chemistry:
Carbamic acid, [(1S)-3-oxocyclopentyl]-, 1,1-dimethylethyl ester (9CI) is also used as a reagent in organic and medicinal chemistry for the development of new drugs. Its versatility allows researchers to explore its potential applications in various chemical reactions and drug synthesis processes.
Used in Biological and Pharmacological Research:
Carbamic acid, [(1S)-3-oxocyclopentyl]-, 1,1-dimethylethyl ester (9CI) has been studied for its potential biological and pharmacological activities. Its unique properties and structure make it a promising candidate for further research and development in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 167298-40-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,2,9 and 8 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 167298-40:
(8*1)+(7*6)+(6*7)+(5*2)+(4*9)+(3*8)+(2*4)+(1*0)=170
170 % 10 = 0
So 167298-40-0 is a valid CAS Registry Number.
167298-40-0Relevant academic research and scientific papers
Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective α(1a)-receptor
Barrow, James C.,Glass, Kristen L.,Selnick, Harold G.,Freidinger, Roger M.,Chang, Raymond S.L.,O'Malley, Stacey S.,Woyden, Carla
, p. 1917 - 1920 (2007/10/03)
Several 1,3-diaminocyclopentane linked α(1a)-receptor antagonists were prepared using a divergent chemical strategy that allows for rapid analysis of all stereochemical permutations for their effect on α1-receptor binding. (C) 2000 Published by Elsevier Science Ltd.
2-6-diaminopurine precursors
-
, (2008/06/13)
The present invention relates to compounds of formula (IV): STR1 wherein Ra and Rb each represent a hydrogen atom or together form an alkylidene group.
